Table 1 Treatments at baseline and at year 2
Baseline N = 729 | Visit at year 2 N = 688 | |
|---|---|---|
Antidiabetic treatment (% of the treated patients) | ||
Insulin ± OADa | 62.5 | 72.3 |
OAD only | 37.5 | 27.7 |
Antihypertensive treatment (% of the treated patients) | ||
RAS blockers (at least one) | 92.1 | 86.5 |
ARBs | 62.8 | 59.4 |
ACEi | 39.4 | 35.9 |
DRI | 12 | 8.5 |
Diuretics (at least one) | 77.1 | 80.4 |
Loop diuretic | 54.4 | 61.2 |
Thiazides | 29 | 27.5 |
Antialdosterone | 3.2 | 3.5 |
CCB | 67.5 | 63.9 |
Beta-blockers | 50.3 | 56.5 |
Central acting agents and others | 25.7 | 27.4 |
Other treatments (% of the patients) | ||
Statins | 76.4 | 69.6 |
Antiplatelet therapy | 61.3 | 55.7 |